Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
BRCA mutation
i
Other names:
BRCA, Breast cancer, early onset
Associations
(3)
News
Trials
B | Sensitive
D | Sensitive
B | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
PARP Inhibitors
Tyrosine Kinase Inhibitors
Chemotherapy
DNA
CD Protein Inhibitors
Immunotherapy
Cancel
HER2 Negative Breast Cancer
Pancreatic Ductal Adenocarcinoma
Diffuse Large B Cell Lymphoma
rivoceranib + fluzoparib
B
BRCA mutation
|
HER2 Negative Breast Cancer
|
rivoceranib + fluzoparib
loncastuximab tesirine-lpyl
D
BRCA mutation
|
Diffuse Large B Cell Lymphoma
|
loncastuximab tesirine-lpyl
PARP inhibitor
D
BRCA mutation
|
Pancreatic Ductal Adenocarcinoma
|
PARP inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
